使用行政数据来预测早产的结果 (EB-POC):来自澳大利亚新生儿网络的链接研究的协议
Mohamed Abdel-Latif1,2,3, Priyal Nanda4, Gonzalo Ovalles5
1Department of Neonatology, Centenary Hospital for Women and Children, Canberra Hospital, Garran, Canberra, ACT, Australia abdel-latif.mohamed@act.gov.au.
BMJ open
|January 7, 2026
概括
这项研究开发了一种基于证据的早产结果计算器 (EB-POC),使用澳大利亚相关数据来预测早产婴儿的死亡率,医院并发症和神经障碍. 该EB-POC将为家长和临床医生提供个性化的风险评估.
科学领域:
- 围产儿医学 围产儿医学
- 生物统计学 生物统计学
- 公共卫生 公共卫生
背景情况:
- 医疗保健提供者需要准确的数据,以向极度早产婴儿的父母提供有关死亡和发病风险的建议.
- 父母寻求个性化信息,了解他们的婴儿的生存机会,医院并发症和神经发育结果.
- 现有的数据缺乏针对婴儿特定的产前和产周风险因素的个性化.
研究的目的:
- 设计,建模,构建和验证基于证据的早产期结果计算器 (EB-POC).
- 预测早产婴儿的关键结果,包括死亡率,医院发病率和神经障碍.
- 为产周护理提供个性化,基于证据的决策支持.
主要方法:
- 一项队列研究,将澳大利亚首都地区和新南威尔士州的八个行政数据库的数据联系起来.
- 包括2007年1月1日至2022年12月31日期间的所有出生.
- 数据分析使用Minitab和R软件进行结果预测.
主要成果:
- 该研究正在开发EB-POC来预测早产婴儿的死亡率,医院疾病和神经障碍.
- 使用链接的人口数据验证EB-POC.
- 预计将于2025年12月发布结果.
结论:
- 该EB-POC旨在为家长和临床医生增强个性化,基于证据的决策.
- 该工具可以通过网站和移动应用程序访问,将支持预产婴儿的潜在父母.
- 该计算器将为明智的咨询和护理计划提供关键的结果数据.
更多相关视频
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
15.0K
05:15Author Spotlight: Assessing the Feasibility of Using Amplitude-Integrated EEG During Neonatal Transport
Published on: June 21, 2024
1.2K
相关概念视频
01:52Regression Toward the Mean
6.8K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.8K
01:12Analysis of Population Pharmacokinetic Data
671
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
671